STERIS plc (STE)

Currency in USD
208.00
+0.78(+0.38%)
Real-time Data·
STE is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
205.13209.36
52 wk Range
195.14269.44
Key Statistics
Prev. Close
207.22
Open
208.11
Day's Range
205.13-209.36
52 wk Range
195.14-269.44
Volume
157.52K
Average Volume (3m)
782.71K
1-Year Change
-14.2073%
Book Value / Share
73.25
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
STE Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
256.86
Upside
+23.49%
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a low P/E ratio relative to near-term earnings growth

STERIS plc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Neutral
Moving Averages
Sell

Analyst Ratings

6 Buy
2 Hold
0 Sell
Ratings:
8 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 256.86
(+23.49% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Piper Sandler
Buy270.00+29.88%-MaintainMay 21, 2026
KeyBanc
Buy269.00+29.40%291.00MaintainMay 13, 2026
Jefferies
Hold256.00+23.15%-MaintainFeb 05, 2026
Citizens
Buy280.00+34.69%-MaintainFeb 05, 2026
Citizens
Buy280.00+34.69%-MaintainFeb 04, 2026

STERIS plc SWOT Analysis


Infection Prevention Leade
STERIS plc, a key player in healthcare infection prevention, showcases consistent growth and financial stability in a critical market secto
Financial Resilience
Explore STERIS's track record of mid-single-digit sales growth and double-digit EPS growth, with analyst price targets ranging from $265 to $280
Market Positioning
Delve into STERIS's premium valuation, driven by its non-elective product portfolio and strong execution in the healthcare and life sciences industries
Challenges Ahead
Learn about STERIS's strategies to navigate ongoing EtO litigation, rising input costs, and evolving regulatory environments while maintaining market leadership
Read full SWOT analysis

STERIS plc Earnings Call Summary for Q4/2026

  • STERIS reported record $6B revenue for fiscal 2026 (up 9% YoY); Q4 revenue hit $1.6B, beating estimates but EPS of $2.83 missed forecast by $0.02
  • Adjusted EPS grew 10% for full year despite tariff headwinds; EBIT margin expanded 10bps to 23.3% while free cash flow surged to $982.9M
  • Stock rose 2.31% in aftermarket trading to $215.89, reflecting investor confidence despite slight earnings miss and macroeconomic challenges
  • Company projects FY2027 EPS of $11.23 and revenue of $6.32B, driven by strategic pricing adjustments and operational efficiencies
  • Management cited product innovation and market expansion as growth drivers while addressing tariff impacts through pricing strategies and cost controls
Last Updated: 2026-05-14, 09:10 p/m
Read Full Transcript

Earnings

Latest Release
May 11, 2026
EPS / Forecast
2.83 / 2.85
Revenue / Forecast
1.6B / 1.59B
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 7.93%
Dividend Yield
1.21%
Industry Median 1.66%
Annualized payout
2.52
Paid quarterly
5-Years Growth
+9.40%
Growth Streak

STE Income Statement

Compare STE to Peers and Sector

Metrics to compare
STE
Peers
Sector
Relationship
P/E Ratio
26.1x30.8x−0.5x
PEG Ratio
0.930.240.00
Price/Book
2.8x2.5x2.6x
Price / LTM Sales
3.4x2.3x3.0x
Upside (Analyst Target)
29.8%23.2%58.6%
Fair Value Upside
Unlock28.3%10.2%Unlock

STERIS plc provides infection prevention products and services in the United States, Ireland, and internationally. It operates through three segments: Healthcare, Applied Sterilization Technologies, and Life Sciences. The company offers cleaning chemistries and sterility assurance products, automated endoscope reprocessing system and tracking products, endoscopy accessories, instruments, washers, and sterilizers and other pieces of capital equipment, as well as equipment used directly in the procedure rooms, including surgical tables, lights, equipment management services, and connectivity solutions; and various preventive maintenance programs, repair services, custom process improvement consulting, and outsourced instrument sterile processing, as well as instrument, devices, and endoscope repair and maintenance services. It also provides process controls and monitoring systems, as well as integrated sterilization equipment, such as accelerators, product handling, and automation; and sterilization modalities, product development, materials testing, and process validation, as well as support services for sterilization equipment and control systems comprising installation, preventive maintenance, updates, repairs, and troubleshooting. In addition, the company offers pharmaceutical detergents, cleanroom disinfectants and sterilants, pharmaceutical grade and research sterilizers and washers, sterility assurance and maintenance products, vaporized hydrogen peroxide room decontamination systems and sterilizers, and high purity water and pure steam generators; and preventive maintenance programs and repair services to support the operation of capital equipment. It serves healthcare providers, medical device and pharmaceutical manufacturers, biopharmaceutical manufacturing facilities, and hospitals. The company was formerly known as New STERIS Limited and changed its name to STERIS plc in November 2015. STERIS plc was founded in 1985 and is headquartered in Mentor, Ohio.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
53.89M55.22%11.17B
Other Institutional Investors
43.66M44.73%9.05B
Public Companies & Retail Investors
52.06K0.05%10.79M
Total
97.6M100.00%20.23B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
BlackRock, Inc.9.25%9,026,6211,870,496
Vanguard Capital Management, LLC6.52%6,366,3781,319,241

People Also Watch

264.23
WTW
+1.32%
47.12
ROL
+0.15%
130.76
TFX
+1.12%
99.32
RVTY
-2.17%
129.23
HIG
+0.65%

FAQ

What Is the STERIS (STE) Stock Price Today?

The STERIS stock price today is 208.00 USD.

What Stock Exchange Does STERIS Trade On?

STERIS is listed and trades on the New York Stock Exchange.

What Is the Stock Symbol for STERIS?

The stock symbol for STERIS is "STE."

Does STERIS Pay Dividends? What’s The Current Dividend Yield?

The STERIS dividend yield is 1.18%.

What Is the STERIS Market Cap?

As of today, STERIS market cap is 20.35B USD.

What Is STERIS's Earnings Per Share (TTM)?

The STERIS EPS (TTM) is 7.93.

When Is the Next STERIS Earnings Date?

STERIS will release its next earnings report on Aug 10, 2026.

From a Technical Analysis Perspective, Is STE a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has STERIS Stock Split?

STERIS has split 2 times.

How Many Employees Does STERIS Have?

STERIS has 17937 employees.

What is the current trading status of STERIS (STE)?

As of Jun 12, 2026, STERIS (STE) is trading at a price of 208.00 USD, with a previous close of 207.22 USD. The stock has fluctuated within a day range of 205.13 USD to 209.36 USD, while its 52-week range spans from 195.14 USD to 269.44 USD.

What Is STERIS (STE) Price Target According to Analysts?

The average 12-month price target for STERIS is 256.86 USD, with a high estimate of 280 USD and a low estimate of 225 USD. 6 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +23.49% Upside potential.

What Is the STE Premarket Price?

STE's last pre-market stock price is 206.90 USD. The pre-market share volume is 10.00, and the stock has decreased by -0.32, or -0.15%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.